Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2008
10/23/2008US20080260805 Water degradation; controlled drying; digestible film containing water soluble polymer
10/23/2008US20080260803 Producing eye insertable drug delivery agent; extruding active ingredient with polyvinyl alcohol free biodegradable polymer
10/23/2008US20080260801 Composite material, especially for medical use, and method for producing the material
10/23/2008US20080260795 Water gellant containing polymer with hydrogen bonding; hydrophobic linkage
10/23/2008US20080260793 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof
10/23/2008US20080260792 Method to Use Therapeutic Microencapsulation of Embedding Parathyroid Live Cells with Theracyte
10/23/2008US20080260791 Reducing pain; in situ administering dosage
10/23/2008US20080260790 Increase acoustic deposits at target using plasmid; nanostructure biocompatible solid; plasmid intensifier comprises a core material encapsulated by membrane in aqueous solution
10/23/2008US20080260788 Antiseptic; mixture of alcohol and halogen compound; bactericides, viricides, fungicides
10/23/2008US20080260787 Use of Collagen in Combination With Oxygen- and Ozone-Releasing Perfluorocarbons For the Preparation of a Medicament For the Treatment of Skin Lesions
10/23/2008US20080260785 Mixture of paroxetine with acid resistant polymer; sustained release; bioavailability
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260725 Tag and target delivery system
10/23/2008US20080260697 Using controlled release bacteriophage as therapeutic to manage feedlot target pathogens; reducing pathogenic microorganisms in animal enclosures
10/23/2008US20080260677 Transdermal Topical Composition and Its Uses
10/23/2008US20080260657 Process for Milling Poorly Soluble Drugs in Presence of Liquid Propellants
10/23/2008US20080260656 Ungual/periungual compositions comprising morpholine compounds and water-soluble film-forming agents
10/23/2008US20080260655 stable, non-alcoholic, non-silicone, foamable carrier compositions comprising petrolatum, foam agent, propellant,
10/23/2008US20080260654 Drug incorporated into carrier substrate of hyaluronic acid, amino acid or polyoxyalkylene glycol
10/23/2008US20080260653 Topical chelation compounds; applying to skins of humans, animals
10/23/2008US20080260648 Pharmaceutical Preparation Containing Magnetic Vesicular Particles, Manufacturing Method Thereof and Diagnostic Therapeutic System
10/23/2008DE10341317B4 Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid The transdermal therapeutic system (TTS) except for the administration of pergolide ergoline compounds
10/23/2008CA2721133A1 Low-dose doxepin formulations and methods of making and using the same
10/23/2008CA2721131A1 Freezable unit dosage delivery system and method of preparation
10/23/2008CA2684219A1 Oral cephalotaxine dosage forms
10/23/2008CA2684052A1 Novel strategies for delivery of active agents using micelles and particles
10/23/2008CA2683777A1 Formulation of active agent loaded activated plga nanoparticles for targeted cancer nano-therapeutics
10/23/2008CA2683603A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008CA2682929A1 Pharmaceutical compositions comprising irbesartan
10/23/2008CA2682378A1 Suspension for visualization of transparent tissue in eye
10/23/2008CA2681432A1 Film-like orally administered medication and manufacturing method therefor
10/23/2008CA2679929A1 Method for producing finely pulverized organic compound particle
10/23/2008CA2678455A1 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
10/23/2008CA2672024A1 Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
10/23/2008CA2666322A1 Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
10/22/2008EP1982726A1 Novel vaccine carrier
10/22/2008EP1982705A1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application
10/22/2008EP1982703A2 A transpulmonary composition
10/22/2008EP1982702A1 Sirolimus formulation
10/22/2008EP1982701A2 Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
10/22/2008EP1982700A1 Positively and negatively charged microparticles.
10/22/2008EP1982699A1 A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation
10/22/2008EP1982698A1 Preparations for controlled release of natural bioactive materials
10/22/2008EP1982697A1 Emulsion lotion
10/22/2008EP1982696A1 Gel for treating wounds
10/22/2008EP1982695A2 Manufacture of long term drug delivery devices with polyurethane
10/22/2008EP1982694A1 Anti-oedema composition
10/22/2008EP1982690A2 Device for smoothing wrinkles on human skin
10/22/2008EP1981545A2 Pharmaceutical formulations
10/22/2008EP1981496A1 A pharmaceutical composition comprising perindopril
10/22/2008EP1981494A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
10/22/2008EP1981490A1 Long term weight maintenance
10/22/2008EP1981487A1 Latex or pseudolatex compositions coatings and coating processes
10/22/2008EP1981486A2 Polymeric implant and a process for obtaining a polymeric implant
10/22/2008EP1981485A1 Solid pharmaceutical composition comprising irbesartan
10/22/2008EP1981484A2 Pharmaceutical composition comprising high-potency sweetener
10/22/2008EP1981483A1 Technology for preparation of macromolecular microspheres
10/22/2008EP1981482A1 Process for preparing a particle comprising a biological molecule and a carrier polymer
10/22/2008EP1981481A2 Oral, pulmonary and transmucosal delivery composition
10/22/2008EP1981480A1 Foam-forming composition
10/22/2008EP1981479A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
10/22/2008EP1981478A2 Central administration of stable formulations of therapeutic agents for cns conditions
10/22/2008EP1981477A1 A topical composition comprising an antibacterial substance
10/22/2008EP1981476A2 Pharmaceutical formulations
10/22/2008EP1981475A2 Pharmaceutical formulations
10/22/2008EP1981474A2 Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
10/22/2008EP1981473A2 Spill resistant antibiotic formulations
10/22/2008EP1981465A2 Method and apparatus for forming delivery devices for oral intake of an agent
10/22/2008EP1677823B1 Botulinum toxin treatments of neurological and neuropsychiatric disorders
10/22/2008EP1675573B1 Controlled release sterile injectable aripiprazole formulation and method
10/22/2008EP1610856B1 Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent
10/22/2008EP1560621A4 Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia sytem
10/22/2008EP1556002B1 Implantable structure for prolonged and controlled release of an active principle
10/22/2008EP1552848B1 Compositions against chicken coccidiosis
10/22/2008EP1395419B1 Preservation of biological materials using fiber-forming techniques
10/22/2008EP1207850B1 Strip pack
10/22/2008EP1037687B8 Device for enhancing transdermal agent flux
10/22/2008EP0854729B2 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008EP0549592B2 Stabilized retinoid-containing skin care compositions
10/22/2008CN201135618Y Self-heating type cataplasms
10/22/2008CN101291685A Exendin for treating diabetes and reducing body weight
10/22/2008CN101291659A Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
10/22/2008CN101291658A Compositions and methods for preparation of poorly water soluble drugs with increased stability
10/22/2008CN101291657A Alpha1-receptor antagonist slow-release pill preparation and its preparation method
10/22/2008CN101291656A Preparation with accurate dose-dividing function
10/22/2008CN101291655A Dispersible tablets comprising DEFERASIROX
10/22/2008CN101291654A Polymorph transformation of zolpidem in tablet matrix
10/22/2008CN101291653A Lipid encapsulated interfering rna
10/22/2008CN101291652A Semi-permeable compositions providing reduced drying time for osmotic dosage forms
10/22/2008CN101289495A Selenium-containing pentapeptide compounds and uses thereof
10/22/2008CN101288772A Novel medical hot melt resin carrier gel matrix and its preparation method and application
10/22/2008CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
10/22/2008CN101288762A Chinese medicinal composition for treating disease that postpartum lochia can't go and preparation method and quality control method thereof
10/22/2008CN101288761A Chinese tmedicine preparation for treating depression and its preparation method
10/22/2008CN101288758A Analgesic medicine
10/22/2008CN101288757A Medicine composition for treating children fastidium and its preparation method
10/22/2008CN101288756A Chinese traditional medicine for treating chronic colitis
10/22/2008CN101288754A Huyuebao preparation